Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 40
Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 121
Health Care M&A Deals, November 20, 2020
The Health Care M&A deals chart is a selection of transactions announced during the prior week(s). The M&A transactions presented here are from our HealthCareMandA.com Deal Database, which is updated daily to provide our subscribers with the most up-to-date information and trends in the healthcare industry. The largest deal of the week is CBPO Holdings Limited’s acquisition of China Biologic Products Holdings, Inc. (NASDAQ: CBPO) for $4.76 billion. Based in Beijing, China Biologic Products Holdings is a leading, fully integrated plasma-based biopharmaceutical company. The company’s products are used as critical therapies during medical emergencies and for the prevention... Read More »
Cano Health Goes Public in Reverse Merger
Cano Health, LLC has been an active buyer in the healthcare space for the past few years, reporting a couple of deals in 2020 alone. Now the primary care operator is going public in a new reverse merger with Jaws Acquisition Corp. (NYSE: JWS), a special purpose acquisition company. The deal is valued at $4.4 billion. Cano Health is expected to generate $1.45 billion in revenues in 2021. The company operates primary care centers and supports affiliated medical practices in Florida, Texas, Nevada and Puerto Rico that specialize in value-based care for seniors. As part of its care coordination strategy, Cano Health provides high-touch population health management programs such as wellness... Read More »
Healthpeak Properties Acquires MOB and Life Science Portfolio
One of healthcare’s largest REITs is back with two new portfolio acquisitions. Healthpeak Properties, Inc. (NYSE: PEAK), which was formerly known as HCP, Inc., has been an active buyer and seller in the Long-Term Care sector over the past several years, according to search results in our Healthcare Deal Database, but now the REIT is investing in the medical office building (MOB) and life sciences market. Both of these deals were disclosed in the company’s third-quarter earnings report. First, Healthpeak purchased Cambridge Discovery Park, a 607,000 square foot Class-A life science campus in the West Cambridge submarket of Boston, for $664 million. The property has stabilized cash and GAAP... Read More »
Addus HomeCare Buys Queen City Hospice
The hospice market has been booming in 2020, with a string of high-profile mergers and sales for hospice providers. Last week, Addus HomeCare Corporation (NASDAQ: ADUS) continued the trend with the acquisition of Queen City Hospice, LLC for $192 million in cash, representing $162.8 million of value plus $29.2 million in net present value of estimated tax benefits. Queen City Hospice currently serves an average daily census of approximately 900 patients across the state of Ohio, including patients in the Cincinnati, Columbus and Dayton markets. It was a portfolio company of Stonehenge Partners. The provider has generated EBITDA of $8 million and an annualized revenue of $56 million. The... Read More »
Centene Corporation Adds Digital Health Analytics Firm
Centene Corporation (NYSE: CNC), the managed care giant, has acquired Apixio Inc. to boost its healthcare analytics capabilities. Terms of the deal were not disclosed. San Mateo, California-based Apixio provides a technology suite that mines, compiles and analyzes large volumes of disparate, unstructured patient data (such as physician notes and medical charts), and creates and refines algorithms to extract high-quality insights to support payers’ and providers’ administrative activities. Apixio’s AI platform has been trained to handle the complexities and challenges of the healthcare industry and deliver proven results. Apixio will remain an operationally independent entity as part of... Read More »
Health Care M&A Deals, November 13, 2020
The Health Care M&A deals chart is a selection of transactions announced during the prior week(s). The M&A transactions presented here are from our HealthCareMandA.com Deal Database, which is updated daily to provide our subscribers with the most up-to-date information and trends in the healthcare industry. The largest deal of the week is Cano Health, LLC’s reverse merger with Jaws Acquisition Corp., a special purpose acquisition company. The deal is valued at $4.4 billion. Cano Health operates primary care centers and supports affiliated medical practices in Florida, Texas, Nevada, and Puerto Rico that specialize in value-based care for seniors. As part of its care... Read More »
WELL Health Expands Telehealth Portfolio
WELL Health Technologies Corp. (TSX.V: WELL) has been on an acquisition marathon this year. The company has announced six transactions so far, based on search results from our HealthCareMandA.com Deal Database, including a new deal this week for Toronto-based INSIG Corporation. INSIG is a virtual care platform with a SaaS-enabled marketplace currently supporting over 2,800 healthcare practitioners. The platform has performed approximately 200,000 virtual care appointments in the last 90 days and has been used by over 500,000 patients since its inception. WELL Health is a digital health company leveraging the latest technology and trends in digital health. It owns and operates 20 primary... Read More »
Merck Boosts Oncology Portfolio
The pharmaceutical giant Merck & Co., Inc. (NYSE: MRK) has announced a new acquisition, prepping up its oncology product portfolio. Merck purchased VelosBio, a privately held clinical-stage biopharmaceutical company committed to developing first-in-class cancer therapies, for $2.75 billion in cash. VelosBio’s lead investigational candidate, VLS-101, is currently being evaluated in a Phase 1 and a Phase 2 clinical trial for the treatment of patients with hematologic malignancies and solid tumors, respectively. The transaction is expected to close by the end of 2020. Merck has been building up its oncology portfolio in recent months, trying to remain competitive in the growing market,... Read More »
Health Care M&A Deals, November 6, 2020
The Health Care M&A deals chart is a selection of transactions announced during the prior week(s). The M&A transactions presented here are from our HealthCareMandA.com Deal Database, which is updated daily to provide our subscribers with the most up-to-date information and trends in the healthcare industry. The largest deal of the week is Merck & Co., Inc.’s acquisition of VelosBio for $2.75 billion in cash. VelosBio is a privately held clinical-stage biopharmaceutical company committed to developing first-in-class cancer therapies. VelosBio’s lead investigational candidate, VLS-101, is currently being evaluated in a Phase 1 and a Phase 2 clinical trial for the treatment... Read More »Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
